CIDRAP newsletters options
The corticosteroid dexamethasone was associated with a 56% lower risk of death and intensive care unit (ICU) admission among hospitalized COVID-19 patients and is safe to use in monitored diabetes patients, according to research presented at this week's Society for Endocrinology annual conference in Edinburgh, Scotland.
A new report from the AMR Industry Alliance (AMRIA) highlights some of the efforts that life sciences companies are pursuing to deliver on commitments to tackle antimicrobial resistance.
The 2021 AMRIA Progress Report draws on a survey completed by 53 alliance members and looks at efforts across four strategic pillars—research and science, access, appropriate use, and manufacturing and the environment.
The data underscore the importance of weighing all possible causes, including COVID-19.
Currently, at least 69% of adult US Pfizer vaccine recipients qualify for a booster dose.
Nations like Denmark and France are now seeing impacts and taking steps to curb the spread of COVID-19.
New data released today by the United Kingdom's Veterinary Medicines Directorate (VMD) show that the use of antibiotics in UK livestock continues to fall.
A coronavirus sharing 92.6% of nucleotide identity with SARS-CoV-2 was detected in bats in Cambodia in 2010, according to a new study in Nature Communications, adding to the understanding of natural reservoirs for the virus causing the COVID-19 pandemic.
Also, tens of thousands of federal workers have requested vaccine exemptions on religious grounds.
Hospital patients in poorer neighborhoods were 28% more likely to have major events like heart attacks and 37% more likely to die.
"The trajectory of the pandemic is in our hands. ... What happens now and into 2022 is up to us."
Over half of adults diagnosed as having a rheumatologic disease reported persistent COVID-19 symptoms at least a month after recovery from their infection, according to survey results presented late last week at the virtual American College of Rheumatology annual meeting.
In a trial, the oral drug Paxlovid reduced the risk of hospitalization or death by 89%.
One study shows 85% protection against hospitalization.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A detailed national survey of Americans, which included residents of the four largest US metropolitan areas, found that about half of those unwilling to be vaccinated against COVID-19 were unlikely to change their minds. A research team based at Emerson University published their findings yesterday in Scientific Reports.
Most pregnant women with a reported history of penicillin allergy who were tested were found not to be allergic and could tolerate penicillin during labor, according to a small retrospective study presented today at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
More than 28 million extra years of life were lost among 31 well-off nations.
The plan will affect all employers with 100 or more employees, or 84 million Americans.
Officials warn that the continent could see another half million COVID-19 deaths by February.
The monetary benefit could be as high as $17 billion if vaccines are affordably priced, the report suggests.
